(Q37865861)

24 August 2017

1 reference

title

Liver fibrogenic cells (English)

1 reference

24 August 2017

2

1 reference

24 August 2017

Stuart J Forbes

1

0 references

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21497739

30 November 2024

publication date

1 April 2011

1 reference

24 August 2017

April 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21497739

full work available at URL

30 November 2024

https://api.elsevier.com/content/article/PII:S1521691811000321?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

https://api.elsevier.com/content/article/PII:S1521691811000321?httpAccept=text/plain

30 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Best Practice and Research: Clinical Gastroenterology

30 November 2024

published in

1 reference

24 August 2017

volume

25

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

207-217

1 reference

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

24 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Oxidative stress-related molecules and liver fibrosis

30 November 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Liver fibrosis -- from bench to bedside

30 November 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications

30 November 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

30 November 2024

Liver fibrosis

5

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Mechanisms of hepatic fibrogenesis

30 November 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario.

30 November 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Hepatic fibrogenesis: from within and outwith

30 November 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Mechanisms of fibrogenesis

30 November 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Portal fibroblasts: Underappreciated mediators of biliary fibrosis

30 November 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Liver fibrosis: from the bench to clinical targets

30 November 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research

30 November 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

30 November 2024

Hepatic wound repair

13

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers

30 November 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver

30 November 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Epithelial-to-mesenchymal transitions in the liver

30 November 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Epithelial-mesenchymal transition: from molecular mechanisms, redox regulation to implications in human health and disease

30 November 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Cytokine receptors and signaling in hepatic stellate cells

30 November 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells

30 November 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Redox mechanisms in hepatic chronic wound healing and fibrogenesis

30 November 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells.

30 November 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells

30 November 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Angiogenesis in chronic inflammatory liver disease

30 November 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Angiogenesis in liver disease

30 November 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Angiogenesis and liver fibrogenesis

30 November 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Ito cells, stellate cells, and myofibroblasts: new actors in antigen presentation

30 November 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver

30 November 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

CD133 hepatic stellate cells are progenitor cells

30 November 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers

30 November 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development

30 November 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis

30 November 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries

30 November 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling.

30 November 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.

30 November 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Critical review of clinical trials of bone marrow stem cells in liver disease.

30 November 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Commitment of bone marrow cells to hepatic stellate cells in mouse

30 November 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

The bone marrow functionally contributes to liver fibrosis

30 November 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Pathological roles of bone marrow-derived stellate cells in a mouse model of alcohol-induced fatty liver.

30 November 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Participation of bone marrow cells in biliary fibrosis after bile duct ligation

30 November 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis

30 November 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis

30 November 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Bone marrow stem cells contribute to alcohol liver fibrosis in humans

30 November 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential

30 November 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice.

30 November 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis.

30 November 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair

30 November 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Hepatic recruitment of the inflammatory Gr1 monocyte subset upon liver injury promotes hepatic fibrosis

30 November 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

The fractalkine receptor CX₃CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes

30 November 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver

30 November 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Complex networks orchestrate epithelial-mesenchymal transitions

30 November 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Biomarkers for epithelial-mesenchymal transitions

30 November 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease.

30 November 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

The basics of epithelial-mesenchymal transition

30 November 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition.

30 November 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis

30 November 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice

30 November 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice

30 November 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.BPG.2011.02.006

30 November 2024

Identifiers

1 reference

24 August 2017

1 reference